华峰化学所属申万行业为：基础化工-化学纤维-氨纶。所属概念板块包括：社保重仓、可降解、MSCI 中国、融资融券、大盘等。 截至9月30日，华峰化学股东户数4.84万，较上期减少25.68%；人均流通股102258股，较上期增加 34.55%。2025年1月-9月，华峰化学实现营业收入181.09亿元，同比减少11.11%；归母净利润14.62亿 元，同比减少27.45%。 1月9日，华峰化学盘中上涨2.04%，截至13:13，报11.98元/股，成交3.11亿元，换手率0.53%，总市值 594.51亿元。 资金流向方面，主力资金净流入2998.08万元，特大单买入3639.49万元，占比11.71%，卖出782.86万 元，占比2.52%；大单买入4900.74万元，占比15.77%，卖出4759.29万元，占比15.32%。 华峰化学今年以来股价涨8.91%，近5个交易日涨8.91%，近20日涨31.36%，近60日涨37.39%。 资料显示，华峰化学股份有限公司位于浙江省温州市瑞安市瑞安经济开发区开发区大道1788号，成立日 期1999年12月15日，上市日期2006年8月23日，公司主营业务涉及从事氨 ...

分红方面，华峰化学A股上市后累计派现51.24亿元。近三年，累计派现24.81亿元。 机构持仓方面，截止2025年9月30日，华峰化学十大流通股东中，香港中央结算有限公司位居第五大流 通股东，持股7251.73万股，相比上期增加339.48万股。鹏华中证细分化工产业主题ETF联接A （014942）位居第六大流通股东，持股2981.30万股，为新进股东。南方中证500ETF（510500）位居第 七大流通股东，持股2889.80万股，相比上期减少56.27万股。 责任编辑：小浪快报 资料显示，华峰化学股份有限公司位于浙江省温州市瑞安市瑞安经济开发区开发区大道1788号，成立日 期1999年12月15日，上市日期2006年8月23日，公司主营业务涉及从事氨纶纤维、聚氨酯原液、己二酸 等聚氨酯制品材料的研发、生产与销售。主营业务收入构成为：基础化工产品36.84%，化学纤维 34.73%，化工新材料22.81%，其他5.06%，物流服务0.56%。 华峰化学所属申万行业为：基础化工-化学纤维-氨纶。所属概念板块包括：社保重仓、可降解、MSCI 中国、融资融券、大盘等。 截至9月30日，华峰化学股东户数4.84万， ...

资料显示，华峰化学股份有限公司位于浙江省温州市瑞安市瑞安经济开发区开发区大道1788号，成立日 期1999年12月15日，上市日期2006年8月23日，公司主营业务涉及从事氨纶纤维、聚氨酯原液、己二酸 等聚氨酯制品材料的研发、生产与销售。主营业务收入构成为：基础化工产品36.84%，化学纤维 34.73%，化工新材料22.81%，其他5.06%，物流服务0.56%。 华峰化学所属申万行业为：基础化工-化学纤维-氨纶。所属概念板块包括：社保重仓、MSCI中国、可 降解、融资融券、大盘等。 截至9月30日，华峰化学股东户数4.84万，较上期减少25.68%；人均流通股102258股，较上期增加 34.55%。2025年1月-9月，华峰化学实现营业收入181.09亿元，同比减少11.11%；归母净利润14.62亿 元，同比减少27.45%。 12月29日，华峰化学盘中下跌2.06%，截至14:25，报10.95元/股，成交5.07亿元，换手率0.92%，总市值 543.40亿元。 资金流向方面，主力资金净流出677.54万元，特大单买入6811.82万元，占比13.43%，卖出6583.48万 元，占比12.98% ...

Core Viewpoint - The sale of 100% equity in Chongqing Futong Logistics Co., Ltd. for 348 million yuan marks a deepening of the company's strategy to focus on its core polyurethane business, as logistics contributes less than 1% to total revenue [2][4]. Group 1: Asset Divestiture - The divestiture of Futong Logistics, which has been profitable, indicates the company's commitment to concentrating resources on its main business and avoiding distractions from non-core operations [2][5]. - The transaction is based on an asset valuation report, with a valuation increase of 135 million yuan, representing a 63.27% appreciation [3]. Group 2: Financial Performance of Futong Logistics - Futong Logistics reported a revenue of 181 million yuan and a net profit of 47.99 million yuan in 2024, with a cash flow from operating activities of 88.44 million yuan [3]. - In the first three quarters of 2025, the revenue grew by 6.63% to 193 million yuan, while net profit was 36.63 million yuan [3]. Group 3: Strategic Focus on Core Business - The logistics segment accounted for only 0.56% of total revenue in the first half of 2025, emphasizing the company's focus on high-value core operations [5]. - The company has previously engaged in asset restructuring, including the sale of part of its stake in Chongqing Huafeng Chemical for 820 million yuan to support cash flow and R&D investments [5]. Group 4: Industry Context and Challenges - The polyurethane industry is facing challenges from overcapacity and declining prices, leading to a strategic adjustment by the company [7][8]. - The company's revenue and net profit have shown a downward trend from 2022 to 2024, with a significant drop in net profit by 64.17% in 2022 [8].

全球氨纶巨头华峰化学（002064.SZ）正在筹划出售资产，进一步聚焦核心主业。 12月19日晚，华峰化学公告，经公司董事会审议通过，公司将全资子公司重庆涪通物流有限公司（简 称"涪通物流"）100%股权转让给公司关联方华峰物流。参考评估值，本次交易价格为3.48亿元。 长江商报消息 ●长江商报记者 沈右荣 华峰化学称，本次出售资产，是为了优化资产配置，聚焦主业。 华峰化学是全球氨纶龙头，核心业务为公司贡献超99%的营业收入，物流服务收入占比不足1%。本次 交易完成后，公司将一心一意经营氨纶等核心业务。 华峰化学表示，公司坚持走"做强主业、适度多元、创新驱动、产融结合"的发展道路，聚焦聚氨酯产业 链发展，打造上下游产业一体化产业格局。 华峰化学抵御行业周期风险能力较强。2020年以来，公司年度盈利均超过20亿元。 2025年，公司面临周期下行、供给冲击及预期偏弱三重压力。即便如此，前三季度，公司仍然盈利 14.62亿元。 华峰化学财务状况较好。截至2025年9月末，公司资产负债率为26.78%，前三季度的财务费用为负。 盈利物流公司也被出售 为了聚焦主业，华峰化学果断出售非核心资产。 根据公告，12月19日， ...

Group 1: Production Capacity and Cost - The new spandex production capacity will have a lower investment cost per ton compared to previous capacities, enhancing the company's cost advantage and overall competitiveness [2] - The company has no new expansion plans for spandex and adipic acid production, but future plans will depend on market conditions [3][4] - The remaining 75,000 tons of spandex capacity from fundraising projects is expected to be gradually put into production by the end of 2026 [3] Group 2: Market Conditions and Trends - The profitability of adipic acid is currently at a historical low, with the industry undergoing consolidation and increased competition [3] - The release of downstream demand due to economic recovery and anti-involution policies is expected to significantly boost adipic acid consumption [3] - The spandex market is highly competitive, with prices largely following supply and demand dynamics; the industry is moving towards oligopoly and differentiation [3] Group 3: Inventory and Cost Advantages - The current inventory of spandex is approximately 20 days [3] - The Chongqing production base has significant cost advantages over the Ruian base in terms of energy and labor costs [3] Group 4: Future Projects and Developments - The PTMEG project is progressing steadily, with the first phase expected to be completed by the end of next year [4] - The company is the largest spandex producer in China, and the PTMEG project will help stabilize raw material supply and enhance integrated advantages [4] Group 5: Sales and Distribution - The sales model for adipic acid is primarily direct sales, with some reliance on distributors [4] - There are currently no plans for overseas factories [4]

Group 1: Industry Overview - The adipic acid industry is currently at a historical low in profitability, undergoing a phase of consolidation with increased competition and pressure from demand and raw material fluctuations [2] - Economic recovery and policy changes are expected to boost downstream demand for adipic acid products [2] Group 2: Future Demand and Production - The company remains confident in the future demand growth for spandex due to changing consumer preferences and increased application areas [2] - There are no new expansion plans for spandex production at this time [3] Group 3: Financial Performance and Cost Advantages - The spandex segment shows strong profitability driven by a combination of R&D, cost management, and supply chain integration [3] - The Chongqing production base has significant cost advantages over the Ruian base in terms of energy and labor costs [3] Group 4: Production Capacity and Asset Management - The spandex project is progressing steadily, with full production expected by the end of 2026 [3] - The company is committed to completing the acquisition of two assets by December 2026 [3] - There are currently no plans to integrate the nylon 66 business of the controlling shareholder into the listed company [3]

Group 1: Industry Position and Market Dynamics - The spandex product prices and profit levels are currently at historical lows [2][4] - The industry inventory is around 50 days, while the company's inventory is approximately 20 days [3][4] - The spandex market is expected to see limited price rebound in the short term due to supply-demand factors, but long-term demand is projected to grow steadily [3][4] Group 2: Company Expansion and Production Plans - The company has no new expansion plans beyond the ongoing 150,000-ton spandex project, which is expected to be completed by the end of 2026 [2][3] - The PTMEG project is progressing as per the original plan [3] - The company is focusing on its core polyurethane industry chain development and aims to become a leading global player [3][4] Group 3: Raw Material Procurement and Cost Advantages - The company has significant advantages in raw material procurement due to its large-scale production capacity, enhancing negotiation power with suppliers [3] - The company’s adipic acid production benefits from advanced processes that improve material efficiency and reduce costs [3] Group 4: Financial Strategy and Shareholder Returns - The company maintains a cash-rich position and is committed to a balanced approach to investments and dividends, considering both short-term and long-term shareholder interests [3][4] - A structured plan for shareholder returns is being developed, focusing on sustainable and stable returns [3] Group 5: Market Demand and Product Structure - The demand for polyurethane raw materials remains stable, with applications in various industries such as footwear and furniture [3] - Approximately 25% of the company's spandex products are differentiated products, catering to various market segments [3]

Core Viewpoint - Huafeng Chemical's stock has shown a positive trend with a year-to-date increase of 13.03%, despite a decline in revenue and net profit for the first nine months of 2025 [1][2]. Group 1: Stock Performance - On October 31, Huafeng Chemical's stock rose by 2.04%, reaching 9.02 CNY per share, with a trading volume of 143 million CNY and a turnover rate of 0.33%, resulting in a total market capitalization of 44.762 billion CNY [1]. - The stock has experienced a 2.85% increase over the last five trading days, a 2.27% increase over the last 20 days, and a significant 20.91% increase over the last 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, Huafeng Chemical reported a revenue of 18.109 billion CNY, reflecting a year-on-year decrease of 11.11%, and a net profit attributable to shareholders of 1.462 billion CNY, down 27.45% year-on-year [2]. - Cumulative cash dividends since the company's A-share listing amount to 5.124 billion CNY, with 2.481 billion CNY distributed over the last three years [3]. Group 3: Shareholder Information - As of September 30, 2025, the number of Huafeng Chemical's shareholders decreased by 25.68% to 48,400, while the average circulating shares per person increased by 34.55% to 102,258 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 72.5173 million shares, an increase of 3.3948 million shares from the previous period, while the Southern CSI 500 ETF reduced its holdings by 562,700 shares [3].

Core Viewpoint - Huafeng Chemical's stock has shown a mixed performance in recent trading, with a year-to-date increase of 9.02% and a recent decline over the past 20 days [1][2]. Financial Performance - For the period from January to September 2025, Huafeng Chemical reported a revenue of 18.109 billion yuan, a year-on-year decrease of 11.11% [2]. - The net profit attributable to shareholders for the same period was 1.462 billion yuan, down 27.45% year-on-year [2]. Stock Market Activity - As of October 29, Huafeng Chemical's stock price was 8.70 yuan per share, with a trading volume of 72.51 million yuan and a turnover rate of 0.17% [1]. - The company experienced a net outflow of 1.844 million yuan in principal funds, with significant buying and selling activity from large orders [1]. Shareholder Information - As of September 30, 2025, the number of shareholders for Huafeng Chemical was 48,400, a decrease of 25.68% from the previous period [2]. - The average number of circulating shares per shareholder increased by 34.55% to 102,258 shares [2]. Dividend Distribution - Since its A-share listing, Huafeng Chemical has distributed a total of 5.124 billion yuan in dividends, with 2.481 billion yuan distributed over the past three years [3]. Major Shareholders - As of September 30, 2025, Hong Kong Central Clearing Limited was the fifth-largest circulating shareholder, holding 72.5173 million shares, an increase of 3.3948 million shares from the previous period [3]. - The Penghua CSI Sub-Segment Chemical Industry Theme ETF was a new entrant among the top shareholders, holding 29.813 million shares [3].